

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.02328334 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.02328334 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.80530234 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80530234 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.31340646 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.23820088 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.96092102 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.65157415 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.64472502 |
| 10 | cysteine metabolic process (GO:0006534) | 5.63269427 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.57023419 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.57023419 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.57023419 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.47722905 |
| 15 | urea cycle (GO:0000050) | 5.40347803 |
| 16 | urea metabolic process (GO:0019627) | 5.40347803 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.33345387 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.31616640 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.27549916 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.24983820 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 5.13860114 |
| 22 | lysine catabolic process (GO:0006554) | 5.07398219 |
| 23 | lysine metabolic process (GO:0006553) | 5.07398219 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.00694754 |
| 25 | protein carboxylation (GO:0018214) | 5.00694754 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.00025696 |
| 27 | complement activation, alternative pathway (GO:0006957) | 4.98864079 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.97824705 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.92634843 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.91234248 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90305603 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.86614016 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.78159592 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.75553477 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.73664418 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.73664418 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.73664418 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.68898028 |
| 39 | regulation of complement activation (GO:0030449) | 4.67758454 |
| 40 | bile acid metabolic process (GO:0008206) | 4.67633171 |
| 41 | glycine metabolic process (GO:0006544) | 4.54226270 |
| 42 | * alpha-amino acid catabolic process (GO:1901606) | 4.52222662 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.51890817 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.51890817 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.49094166 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 4.47395417 |
| 47 | phospholipid efflux (GO:0033700) | 4.45008201 |
| 48 | serine family amino acid metabolic process (GO:0009069) | 4.42849156 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 4.41818751 |
| 50 | serine family amino acid biosynthetic process (GO:0009070) | 4.40406220 |
| 51 | * glutamate metabolic process (GO:0006536) | 4.39210102 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.30206330 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.27545904 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.27545904 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.26856308 |
| 56 | * cellular amino acid catabolic process (GO:0009063) | 4.25529687 |
| 57 | low-density lipoprotein particle remodeling (GO:0034374) | 4.24187264 |
| 58 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.20465482 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 4.14087839 |
| 60 | ethanol oxidation (GO:0006069) | 4.09153643 |
| 61 | cellular glucuronidation (GO:0052695) | 4.06303279 |
| 62 | * dicarboxylic acid biosynthetic process (GO:0043650) | 4.01953289 |
| 63 | regulation of cholesterol homeostasis (GO:2000188) | 4.01523019 |
| 64 | cholesterol efflux (GO:0033344) | 4.01174218 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 3.98278197 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.92327594 |
| 67 | aspartate family amino acid catabolic process (GO:0009068) | 3.89277602 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 3.88637978 |
| 69 | phospholipid homeostasis (GO:0055091) | 3.87531567 |
| 70 | bile acid and bile salt transport (GO:0015721) | 3.87189271 |
| 71 | short-chain fatty acid metabolic process (GO:0046459) | 3.82071965 |
| 72 | drug catabolic process (GO:0042737) | 3.81447825 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.79079191 |
| 74 | protein-lipid complex assembly (GO:0065005) | 3.79050409 |
| 75 | regulation of plasminogen activation (GO:0010755) | 3.75665705 |
| 76 | arginine metabolic process (GO:0006525) | 3.75267563 |
| 77 | fibrinolysis (GO:0042730) | 3.74555090 |
| 78 | regulation of apoptotic cell clearance (GO:2000425) | 3.74505994 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.73684682 |
| 80 | plasma lipoprotein particle organization (GO:0071827) | 3.73544300 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72734608 |
| 82 | amine catabolic process (GO:0009310) | 3.71329468 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.71329468 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71111692 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 3.68444221 |
| 86 | ketone body metabolic process (GO:1902224) | 3.67899346 |
| 87 | * carboxylic acid catabolic process (GO:0046395) | 3.67445246 |
| 88 | * organic acid catabolic process (GO:0016054) | 3.67445246 |
| 89 | urate metabolic process (GO:0046415) | 3.65654024 |
| 90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.63988486 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.63063781 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.62488515 |
| 93 | sterol homeostasis (GO:0055092) | 3.59831546 |
| 94 | carnitine metabolic process (GO:0009437) | 3.56645294 |
| 95 | protein-lipid complex subunit organization (GO:0071825) | 3.55815698 |
| 96 | lipoprotein metabolic process (GO:0042157) | 3.55142397 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.54554087 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.54554087 |
| 99 | positive regulation of extracellular matrix organization (GO:1903055) | 3.54262332 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53427788 |
| 101 | L-serine metabolic process (GO:0006563) | 3.52167577 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51515261 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51515261 |
| 104 | proline metabolic process (GO:0006560) | 3.50102039 |
| 105 | Golgi transport vesicle coating (GO:0048200) | 3.48162553 |
| 106 | COPI coating of Golgi vesicle (GO:0048205) | 3.48162553 |
| 107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.47440759 |
| 108 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.44837024 |
| 109 | aldehyde catabolic process (GO:0046185) | 3.44390179 |
| 110 | proline biosynthetic process (GO:0006561) | 3.36966774 |
| 111 | regulation of cholesterol metabolic process (GO:0090181) | 3.33529018 |
| 112 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.33347834 |
| 113 | epoxygenase P450 pathway (GO:0019373) | 3.29460459 |
| 114 | negative regulation of lipid transport (GO:0032369) | 3.23991082 |
| 115 | amino acid import (GO:0043090) | 3.14622927 |
| 116 | * glutamine family amino acid biosynthetic process (GO:0009084) | 3.14578352 |
| 117 | sodium ion export (GO:0071436) | 3.12807477 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.11702699 |
| 119 | positive regulation of steroid metabolic process (GO:0045940) | 3.10110126 |
| 120 | negative regulation of protein activation cascade (GO:2000258) | 3.07037094 |
| 121 | low-density lipoprotein particle clearance (GO:0034383) | 3.04060076 |
| 122 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.01383488 |
| 123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.97751610 |
| 124 | positive regulation of blood coagulation (GO:0030194) | 2.95148999 |
| 125 | positive regulation of hemostasis (GO:1900048) | 2.95148999 |
| 126 | regulation of extracellular matrix organization (GO:1903053) | 2.94227252 |
| 127 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.92799034 |
| 128 | protein retention in ER lumen (GO:0006621) | 2.92609182 |
| 129 | acute-phase response (GO:0006953) | 2.92054909 |
| 130 | L-amino acid import (GO:0043092) | 2.91699344 |
| 131 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.91378960 |
| 132 | lipoprotein transport (GO:0042953) | 2.90100276 |
| 133 | negative regulation of hemostasis (GO:1900047) | 2.89606368 |
| 134 | negative regulation of blood coagulation (GO:0030195) | 2.89606368 |
| 135 | protein activation cascade (GO:0072376) | 2.88241316 |
| 136 | COPII vesicle coating (GO:0048208) | 2.87633200 |
| 137 | ethanol metabolic process (GO:0006067) | 2.87582269 |
| 138 | cellular sodium ion homeostasis (GO:0006883) | 2.86981040 |
| 139 | negative regulation of fatty acid transport (GO:2000192) | 2.84552741 |
| 140 | response to mercury ion (GO:0046689) | 2.82544897 |
| 141 | intestinal absorption (GO:0050892) | 2.82351426 |
| 142 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.80986011 |
| 143 | complement activation, classical pathway (GO:0006958) | 2.79466581 |
| 144 | positive regulation of coagulation (GO:0050820) | 2.79029261 |
| 145 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.78913579 |
| 146 | sterol transport (GO:0015918) | 2.78755145 |
| 147 | cholesterol transport (GO:0030301) | 2.78755145 |
| 148 | cellular potassium ion homeostasis (GO:0030007) | 2.78052311 |
| 149 | omega-hydroxylase P450 pathway (GO:0097267) | 2.72147809 |
| 150 | diacylglycerol metabolic process (GO:0046339) | 2.70495705 |
| 151 | acylglycerol catabolic process (GO:0046464) | 2.69833640 |
| 152 | neutral lipid catabolic process (GO:0046461) | 2.69833640 |
| 153 | negative regulation of coagulation (GO:0050819) | 2.64510761 |
| 154 | regulation of humoral immune response (GO:0002920) | 2.64327946 |
| 155 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.63321846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.92176709 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.90652891 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.22649131 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.88251732 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.26231080 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77507335 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.21925192 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.83915038 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.81221991 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33535727 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.30840214 |
| 12 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29722822 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.18475435 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4635774 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.89409822 |
| 16 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88962629 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87865529 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87232923 |
| 19 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.80376190 |
| 20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.75465233 |
| 21 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74729056 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68583223 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55493077 |
| 24 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.48419996 |
| 25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47414322 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47100536 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46758219 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45021044 |
| 29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44358876 |
| 30 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37769448 |
| 31 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36589362 |
| 32 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.35782754 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34178998 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33358335 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29874160 |
| 36 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26801442 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26705572 |
| 38 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26174552 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26019621 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25929730 |
| 41 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23315024 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22072796 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20954813 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18248293 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17434105 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15832608 |
| 47 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15688547 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15251297 |
| 49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15154774 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12415107 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11788453 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11006386 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10975159 |
| 54 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.10844243 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10727858 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10486853 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09474508 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08954048 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06492027 |
| 60 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02653281 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01426072 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00495195 |
| 63 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.00138373 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99821913 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98840746 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97836853 |
| 67 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97516649 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97251773 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94849431 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94224572 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93819577 |
| 72 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92882899 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92591601 |
| 74 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92450764 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91599642 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91244179 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91200884 |
| 78 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89916015 |
| 79 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89683945 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.89587407 |
| 81 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89303734 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89240907 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88690367 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87730040 |
| 85 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87560958 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85354302 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84624736 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82927465 |
| 89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79406585 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74425633 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73573323 |
| 92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72816006 |
| 93 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.71250164 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71235329 |
| 95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.70630704 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69548312 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69548312 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66973639 |
| 99 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.66810011 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66738401 |
| 101 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.66435462 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.65671479 |
| 103 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65546364 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64031477 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63789997 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62740958 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.62503438 |
| 108 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62311127 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60261904 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59723206 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59213843 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.56704100 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.56656093 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.56573207 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53541251 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53297812 |
| 117 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.52560341 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.52439054 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.52017714 |
| 120 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51603419 |
| 121 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.51284395 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50641861 |
| 123 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.49661319 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.49543377 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.48911458 |
| 126 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48889509 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.48828436 |
| 128 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.48065837 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47991147 |
| 130 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47754139 |
| 131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.47707418 |
| 132 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47681039 |
| 133 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.46526844 |
| 134 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.46066584 |
| 135 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44913612 |
| 136 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44807142 |
| 137 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44807142 |
| 138 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.44622827 |
| 139 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.44332044 |
| 140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43968962 |
| 141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43559627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.90102457 |
| 2 | MP0005360_urolithiasis | 7.47649629 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.90410567 |
| 4 | MP0005365_abnormal_bile_salt | 5.85872169 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.62775371 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26728317 |
| 7 | MP0003252_abnormal_bile_duct | 3.90018398 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57541381 |
| 9 | MP0009840_abnormal_foam_cell | 3.43594146 |
| 10 | MP0005332_abnormal_amino_acid | 3.01215524 |
| 11 | MP0005083_abnormal_biliary_tract | 2.91423569 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.72249617 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.54423679 |
| 14 | MP0003195_calcinosis | 2.51325808 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.32591692 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.30894945 |
| 17 | MP0005409_darkened_coat_color | 2.16502857 |
| 18 | MP0000609_abnormal_liver_physiology | 2.16455302 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.15347162 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.10902717 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.09373940 |
| 22 | MP0000920_abnormal_myelination | 1.87995361 |
| 23 | MP0004270_analgesia | 1.87646530 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.79713200 |
| 25 | MP0003868_abnormal_feces_composition | 1.76177420 |
| 26 | MP0000566_synostosis | 1.68673795 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.60964098 |
| 28 | MP0004272_abnormal_basement_membrane | 1.60391475 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.58917034 |
| 30 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.56511166 |
| 31 | MP0002089_abnormal_postnatal_growth/wei | 1.48570852 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.45133271 |
| 33 | MP0003186_abnormal_redox_activity | 1.37928724 |
| 34 | MP0004858_abnormal_nervous_system | 1.37787067 |
| 35 | MP0002254_reproductive_system_inflammat | 1.36064786 |
| 36 | MP0009697_abnormal_copulation | 1.35761749 |
| 37 | MP0003122_maternal_imprinting | 1.35422882 |
| 38 | MP0003091_abnormal_cell_migration | 1.34151574 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.33695232 |
| 40 | MP0001764_abnormal_homeostasis | 1.32804145 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.30207804 |
| 42 | MP0003634_abnormal_glial_cell | 1.30147151 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.28862946 |
| 44 | MP0003632_abnormal_nervous_system | 1.23741255 |
| 45 | MP0000604_amyloidosis | 1.22604421 |
| 46 | MP0000598_abnormal_liver_morphology | 1.20955076 |
| 47 | MP0008260_abnormal_autophagy | 1.17068452 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 1.15428592 |
| 49 | MP0001849_ear_inflammation | 1.10936786 |
| 50 | MP0003879_abnormal_hair_cell | 1.10719086 |
| 51 | MP0003123_paternal_imprinting | 1.08044175 |
| 52 | MP0003690_abnormal_glial_cell | 1.07917368 |
| 53 | MP0003011_delayed_dark_adaptation | 1.07250661 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.05476744 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.03857742 |
| 56 | MP0004130_abnormal_muscle_cell | 1.01821616 |
| 57 | MP0009764_decreased_sensitivity_to | 0.98963105 |
| 58 | MP0003633_abnormal_nervous_system | 0.98413192 |
| 59 | MP0005670_abnormal_white_adipose | 0.98166428 |
| 60 | MP0002009_preneoplasia | 0.97701876 |
| 61 | MP0009763_increased_sensitivity_to | 0.95779303 |
| 62 | MP0005647_abnormal_sex_gland | 0.95181778 |
| 63 | MP0003631_nervous_system_phenotype | 0.91717722 |
| 64 | MP0005451_abnormal_body_composition | 0.90994137 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.90678723 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.89806230 |
| 67 | MP0003941_abnormal_skin_development | 0.86437023 |
| 68 | MP0009053_abnormal_anal_canal | 0.85878450 |
| 69 | MP0000747_muscle_weakness | 0.82562662 |
| 70 | MP0001756_abnormal_urination | 0.82560946 |
| 71 | MP0003300_gastrointestinal_ulcer | 0.82040411 |
| 72 | MP0004233_abnormal_muscle_weight | 0.81668043 |
| 73 | * MP0009642_abnormal_blood_homeostasis | 0.81563409 |
| 74 | MP0002971_abnormal_brown_adipose | 0.81134343 |
| 75 | MP0003075_altered_response_to | 0.80596738 |
| 76 | MP0000537_abnormal_urethra_morphology | 0.80450001 |
| 77 | MP0003329_amyloid_beta_deposits | 0.80360376 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.79729628 |
| 79 | MP0008469_abnormal_protein_level | 0.79386812 |
| 80 | MP0005623_abnormal_meninges_morphology | 0.77467808 |
| 81 | MP0001958_emphysema | 0.77420600 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.77290854 |
| 83 | * MP0002078_abnormal_glucose_homeostasis | 0.76875070 |
| 84 | MP0000003_abnormal_adipose_tissue | 0.75816018 |
| 85 | MP0001730_embryonic_growth_arrest | 0.73353730 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.72646450 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.72358947 |
| 88 | MP0008569_lethality_at_weaning | 0.71438059 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.71262967 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.71240912 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.70866953 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.70817333 |
| 93 | MP0003315_abnormal_perineum_morphology | 0.68982894 |
| 94 | MP0005165_increased_susceptibility_to | 0.68534255 |
| 95 | MP0005334_abnormal_fat_pad | 0.68399506 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.68179197 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.68118516 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.66287389 |
| 99 | MP0005266_abnormal_metabolism | 0.65350947 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.64910521 |
| 101 | MP0005166_decreased_susceptibility_to | 0.64313927 |
| 102 | MP0005535_abnormal_body_temperature | 0.63969562 |
| 103 | MP0002060_abnormal_skin_morphology | 0.62803443 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.62718169 |
| 105 | MP0005621_abnormal_cell_physiology | 0.61998689 |
| 106 | MP0000858_altered_metastatic_potential | 0.60544579 |
| 107 | MP0006054_spinal_hemorrhage | 0.58348959 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.58011349 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.57064808 |
| 110 | MP0005408_hypopigmentation | 0.56778928 |
| 111 | MP0010630_abnormal_cardiac_muscle | 0.54500511 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.54340554 |
| 113 | MP0005448_abnormal_energy_balance | 0.53646187 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.53562130 |
| 115 | MP0001851_eye_inflammation | 0.52831966 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.52739611 |
| 117 | MP0009672_abnormal_birth_weight | 0.51958700 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.51709252 |
| 119 | MP0001661_extended_life_span | 0.51352885 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.50992388 |
| 121 | MP0002168_other_aberrant_phenotype | 0.49917719 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.49558344 |
| 123 | MP0005395_other_phenotype | 0.48331981 |
| 124 | MP0001853_heart_inflammation | 0.47643563 |
| 125 | MP0002928_abnormal_bile_duct | 0.47602971 |
| 126 | MP0003436_decreased_susceptibility_to | 0.44423409 |
| 127 | MP0009115_abnormal_fat_cell | 0.43747929 |
| 128 | MP0008874_decreased_physiological_sensi | 0.43373085 |
| 129 | MP0002796_impaired_skin_barrier | 0.43292812 |
| 130 | MP0004043_abnormal_pH_regulation | 0.41844797 |
| 131 | MP0005023_abnormal_wound_healing | 0.39324371 |
| 132 | MP0000579_abnormal_nail_morphology | 0.39194148 |
| 133 | MP0008873_increased_physiological_sensi | 0.39034552 |
| 134 | MP0001915_intracranial_hemorrhage | 0.38858115 |
| 135 | * MP0003953_abnormal_hormone_level | 0.37523517 |
| 136 | MP0000249_abnormal_blood_vessel | 0.37453745 |
| 137 | MP0002970_abnormal_white_adipose | 0.36593086 |
| 138 | MP0003566_abnormal_cell_adhesion | 0.35992323 |
| 139 | MP0001881_abnormal_mammary_gland | 0.35318059 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.35182571 |
| 141 | MP0004883_abnormal_blood_vessel | 0.35111980 |
| 142 | MP0008961_abnormal_basal_metabolism | 0.34853284 |
| 143 | MP0010352_gastrointestinal_tract_polyps | 0.34651221 |
| 144 | MP0003453_abnormal_keratinocyte_physiol | 0.33371335 |
| 145 | MP0002135_abnormal_kidney_morphology | 0.33322515 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.33193293 |
| 147 | MP0003172_abnormal_lysosome_physiology | 0.32267572 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.32026242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.02949970 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.85073980 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.67475742 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30196132 |
| 5 | Xanthomatosis (HP:0000991) | 6.26191113 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.96851226 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.52347145 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.25297984 |
| 9 | Complement deficiency (HP:0004431) | 4.93610224 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.73527816 |
| 11 | * Hyperammonemia (HP:0001987) | 4.54557216 |
| 12 | Hyperglycinemia (HP:0002154) | 4.54194661 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.52072253 |
| 14 | Hyperglycinuria (HP:0003108) | 4.45130047 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33578330 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.33578330 |
| 17 | Epidermoid cyst (HP:0200040) | 4.33223446 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.32119727 |
| 19 | Ketosis (HP:0001946) | 4.31530533 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.30317171 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22487940 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18892876 |
| 23 | Joint hemorrhage (HP:0005261) | 4.18170818 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00299313 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.88522082 |
| 26 | Fat malabsorption (HP:0002630) | 3.78441380 |
| 27 | Abnormality of complement system (HP:0005339) | 3.66927756 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55586348 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.43011443 |
| 30 | * Hypoglycemic coma (HP:0001325) | 3.32054006 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.29055657 |
| 32 | Ketoacidosis (HP:0001993) | 3.27253068 |
| 33 | Delayed CNS myelination (HP:0002188) | 3.26394132 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24777290 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.20026589 |
| 36 | Myocardial infarction (HP:0001658) | 3.18425567 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.14487250 |
| 38 | Neurofibrillary tangles (HP:0002185) | 3.08791971 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08128179 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.04900712 |
| 41 | Spastic diplegia (HP:0001264) | 3.03943709 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.99955052 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.94442614 |
| 44 | Gout (HP:0001997) | 2.86850807 |
| 45 | Skin nodule (HP:0200036) | 2.84495337 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.84399095 |
| 47 | Scanning speech (HP:0002168) | 2.75855430 |
| 48 | Steatorrhea (HP:0002570) | 2.73137010 |
| 49 | Esophageal varix (HP:0002040) | 2.71287689 |
| 50 | Abnormality of carpal bone ossification (HP:0006257) | 2.69862102 |
| 51 | Protrusio acetabuli (HP:0003179) | 2.68595740 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.67853884 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.64936449 |
| 54 | Vascular calcification (HP:0004934) | 2.63903222 |
| 55 | Flat acetabular roof (HP:0003180) | 2.62317480 |
| 56 | Spontaneous abortion (HP:0005268) | 2.61753520 |
| 57 | Metabolic acidosis (HP:0001942) | 2.60326291 |
| 58 | Acanthocytosis (HP:0001927) | 2.47541643 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46134955 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.46134955 |
| 61 | Neonatal onset (HP:0003623) | 2.45961400 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.41348897 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.40297168 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.40297168 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.39822280 |
| 66 | Sensorimotor neuropathy (HP:0007141) | 2.39520501 |
| 67 | Amyloidosis (HP:0011034) | 2.36661071 |
| 68 | Late onset (HP:0003584) | 2.32024516 |
| 69 | Lethargy (HP:0001254) | 2.31419483 |
| 70 | Irritability (HP:0000737) | 2.28893926 |
| 71 | Abnormal ossification of hand bones (HP:0005921) | 2.27937998 |
| 72 | Malnutrition (HP:0004395) | 2.27854039 |
| 73 | Glomerulonephritis (HP:0000099) | 2.21846606 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21590909 |
| 75 | Mitral stenosis (HP:0001718) | 2.20927091 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.17876145 |
| 77 | Asymmetry of the thorax (HP:0001555) | 2.17822036 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.16991185 |
| 79 | Thrombophlebitis (HP:0004418) | 2.14687948 |
| 80 | Pancreatitis (HP:0001733) | 2.13991970 |
| 81 | Back pain (HP:0003418) | 2.11831070 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.10522335 |
| 83 | Gingival bleeding (HP:0000225) | 2.09121765 |
| 84 | Abnormal cartilage morphology (HP:0002763) | 2.08849994 |
| 85 | Cholelithiasis (HP:0001081) | 2.07841323 |
| 86 | Enlarged kidneys (HP:0000105) | 2.04354954 |
| 87 | Abnormal tarsal ossification (HP:0008369) | 2.03713828 |
| 88 | Ankyloglossia (HP:0010296) | 2.01214764 |
| 89 | Termporal pattern (HP:0011008) | 2.00749740 |
| 90 | Insidious onset (HP:0003587) | 2.00749740 |
| 91 | Status epilepticus (HP:0002133) | 1.99789518 |
| 92 | Abnormal hand bone ossification (HP:0010660) | 1.99349222 |
| 93 | Alkalosis (HP:0001948) | 1.98544647 |
| 94 | Increased purine levels (HP:0004368) | 1.93977889 |
| 95 | Hyperuricemia (HP:0002149) | 1.93977889 |
| 96 | Rickets (HP:0002748) | 1.93828711 |
| 97 | Cholecystitis (HP:0001082) | 1.91718146 |
| 98 | Abnormal gallbladder physiology (HP:0012438) | 1.91718146 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.90454048 |
| 100 | Neonatal death (HP:0003811) | 1.89431244 |
| 101 | Vomiting (HP:0002013) | 1.88728239 |
| 102 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.88622301 |
| 103 | Aplasia of the phalanges of the hand (HP:0009802) | 1.88622301 |
| 104 | Aplasia involving bones of the extremities (HP:0009825) | 1.88622301 |
| 105 | Alacrima (HP:0000522) | 1.87081999 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 1.86674862 |
| 107 | Menorrhagia (HP:0000132) | 1.85787847 |
| 108 | Pseudobulbar signs (HP:0002200) | 1.85163653 |
| 109 | Abnormality of the lumbar spine (HP:0100712) | 1.84767848 |
| 110 | Poikilocytosis (HP:0004447) | 1.83100982 |
| 111 | Proximal tubulopathy (HP:0000114) | 1.82660050 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81052291 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.79678379 |
| 114 | Confusion (HP:0001289) | 1.79077220 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78979770 |
| 116 | Hammertoe (HP:0001765) | 1.78656057 |
| 117 | Purpura (HP:0000979) | 1.78253706 |
| 118 | Bronchomalacia (HP:0002780) | 1.77699517 |
| 119 | Advanced eruption of teeth (HP:0006288) | 1.77006631 |
| 120 | Abnormality of glycolysis (HP:0004366) | 1.76173378 |
| 121 | Abnormality of pain sensation (HP:0010832) | 1.75255883 |
| 122 | Impaired pain sensation (HP:0007328) | 1.75255883 |
| 123 | Arterial tortuosity (HP:0005116) | 1.74924805 |
| 124 | Nephritis (HP:0000123) | 1.74810229 |
| 125 | Cerebral edema (HP:0002181) | 1.74168182 |
| 126 | Stroke (HP:0001297) | 1.74121542 |
| 127 | Reticulocytosis (HP:0001923) | 1.72606381 |
| 128 | Hyperglycemia (HP:0003074) | 1.72416977 |
| 129 | Hyperacusis (HP:0010780) | 1.71365521 |
| 130 | Neonatal short-limb short stature (HP:0008921) | 1.71295562 |
| 131 | Insomnia (HP:0100785) | 1.70228148 |
| 132 | Premature rupture of membranes (HP:0001788) | 1.70098304 |
| 133 | Cerebral aneurysm (HP:0004944) | 1.69697470 |
| 134 | Abnormal delivery (HP:0001787) | 1.67863535 |
| 135 | Achilles tendon contracture (HP:0001771) | 1.62881981 |
| 136 | Vascular tortuosity (HP:0004948) | 1.62133048 |
| 137 | Axonal loss (HP:0003447) | 1.61418093 |
| 138 | Action tremor (HP:0002345) | 1.61169052 |
| 139 | Mucopolysacchariduria (HP:0008155) | 1.60772339 |
| 140 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60772339 |
| 141 | Increased serum pyruvate (HP:0003542) | 1.58866800 |
| 142 | Abnormality of oral frenula (HP:0000190) | 1.57154097 |
| 143 | Wormian bones (HP:0002645) | 1.56740767 |
| 144 | Turricephaly (HP:0000262) | 1.56038243 |
| 145 | Polygenic inheritance (HP:0010982) | 1.55562337 |
| 146 | Dysmetric saccades (HP:0000641) | 1.52725034 |
| 147 | Hemangiomatosis (HP:0007461) | 1.52332693 |
| 148 | Heterotopia (HP:0002282) | 1.50433674 |
| 149 | Supranuclear gaze palsy (HP:0000605) | 1.49873838 |
| 150 | Abnormality of the acetabulum (HP:0003170) | 1.49807991 |
| 151 | Bifid scrotum (HP:0000048) | 1.49641429 |
| 152 | Relative macrocephaly (HP:0004482) | 1.49573470 |
| 153 | Abnormal foot bone ossification (HP:0010675) | 1.49207778 |
| 154 | Renal duplication (HP:0000075) | 1.48804152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.65128929 |
| 2 | SIK1 | 4.16811878 |
| 3 | TRIB3 | 3.99133721 |
| 4 | ERN1 | 3.82789886 |
| 5 | PKN2 | 3.62785831 |
| 6 | FGFR4 | 3.54659841 |
| 7 | ICK | 3.02798617 |
| 8 | PRPF4B | 2.35441953 |
| 9 | ERBB4 | 2.28896785 |
| 10 | LATS1 | 2.05575571 |
| 11 | PTK6 | 2.02358909 |
| 12 | SMG1 | 1.81185784 |
| 13 | NTRK1 | 1.81051357 |
| 14 | FLT3 | 1.80071572 |
| 15 | MAP2K4 | 1.77383228 |
| 16 | RIPK1 | 1.65492309 |
| 17 | CAMK1D | 1.65432117 |
| 18 | TAOK3 | 1.64701039 |
| 19 | NEK9 | 1.59363799 |
| 20 | TYRO3 | 1.57918772 |
| 21 | IRAK3 | 1.57571584 |
| 22 | MST1R | 1.52603567 |
| 23 | NTRK3 | 1.51027492 |
| 24 | MAPK11 | 1.43815386 |
| 25 | NEK1 | 1.41321380 |
| 26 | ARAF | 1.40835331 |
| 27 | INSRR | 1.40503997 |
| 28 | CDK6 | 1.37032542 |
| 29 | MAP3K10 | 1.30311077 |
| 30 | PIK3CG | 1.24075158 |
| 31 | FGFR2 | 1.20898365 |
| 32 | KSR2 | 1.20398736 |
| 33 | JAK2 | 1.17898387 |
| 34 | BMX | 1.16855635 |
| 35 | PBK | 1.12542781 |
| 36 | FRK | 1.10935766 |
| 37 | MAP3K9 | 1.10501685 |
| 38 | LRRK2 | 1.09639355 |
| 39 | MAP3K7 | 1.08972463 |
| 40 | ABL2 | 1.08675140 |
| 41 | TYK2 | 1.04320009 |
| 42 | NEK6 | 1.03715341 |
| 43 | SGK3 | 1.03476177 |
| 44 | GRK6 | 1.02090489 |
| 45 | LMTK2 | 1.00644274 |
| 46 | PRKAA2 | 0.99777787 |
| 47 | SCYL2 | 0.99618867 |
| 48 | ERBB2 | 0.97563381 |
| 49 | MAP2K3 | 0.96578294 |
| 50 | STK10 | 0.94342940 |
| 51 | FGFR3 | 0.90353507 |
| 52 | PTK2 | 0.90267710 |
| 53 | PDGFRA | 0.89660113 |
| 54 | PDGFRB | 0.89507694 |
| 55 | EPHB1 | 0.88330074 |
| 56 | DDR2 | 0.87556485 |
| 57 | MET | 0.87159342 |
| 58 | JAK1 | 0.86264560 |
| 59 | KDR | 0.86158683 |
| 60 | CAMK1G | 0.85640245 |
| 61 | NTRK2 | 0.84989765 |
| 62 | RET | 0.84407994 |
| 63 | TESK1 | 0.83536598 |
| 64 | AKT3 | 0.83394353 |
| 65 | DAPK2 | 0.79400155 |
| 66 | LATS2 | 0.79017091 |
| 67 | WNK1 | 0.78078993 |
| 68 | WNK3 | 0.77781605 |
| 69 | PAK4 | 0.77027657 |
| 70 | MTOR | 0.76159229 |
| 71 | CAMKK1 | 0.74899167 |
| 72 | GSK3A | 0.74100365 |
| 73 | MARK2 | 0.72219058 |
| 74 | PRKACG | 0.71070107 |
| 75 | CDK4 | 0.70957698 |
| 76 | MOS | 0.70508124 |
| 77 | PDPK1 | 0.69485259 |
| 78 | MAP3K11 | 0.68501577 |
| 79 | PAK2 | 0.68005664 |
| 80 | MAP3K3 | 0.67841828 |
| 81 | TBK1 | 0.67159991 |
| 82 | DYRK1B | 0.66769245 |
| 83 | FER | 0.65547291 |
| 84 | MAPK10 | 0.63834154 |
| 85 | PINK1 | 0.63664432 |
| 86 | EPHA2 | 0.63237134 |
| 87 | CSK | 0.62800136 |
| 88 | EIF2AK1 | 0.62463662 |
| 89 | SGK2 | 0.62336822 |
| 90 | MAP3K8 | 0.61780987 |
| 91 | FGFR1 | 0.61678220 |
| 92 | RPS6KB1 | 0.61045363 |
| 93 | STK38L | 0.60789418 |
| 94 | PRKCZ | 0.60538797 |
| 95 | PAK3 | 0.60526080 |
| 96 | MAPK4 | 0.60317181 |
| 97 | RAF1 | 0.59810747 |
| 98 | ROCK2 | 0.59729133 |
| 99 | PRKAA1 | 0.58820934 |
| 100 | MAP3K5 | 0.57982581 |
| 101 | PRKD3 | 0.56460403 |
| 102 | EPHA4 | 0.56363394 |
| 103 | CDK15 | 0.55944480 |
| 104 | PDK1 | 0.55348108 |
| 105 | STK38 | 0.53117380 |
| 106 | MAP3K2 | 0.52835516 |
| 107 | UHMK1 | 0.52280576 |
| 108 | MAP2K1 | 0.52027932 |
| 109 | MAPK12 | 0.50999218 |
| 110 | CDK18 | 0.50903386 |
| 111 | BRAF | 0.50130643 |
| 112 | TGFBR2 | 0.49577632 |
| 113 | CDK14 | 0.49324516 |
| 114 | EEF2K | 0.48582245 |
| 115 | MINK1 | 0.48355344 |
| 116 | SGK1 | 0.47584612 |
| 117 | CDK11A | 0.47301774 |
| 118 | EGFR | 0.45075039 |
| 119 | YES1 | 0.42913460 |
| 120 | CDK12 | 0.42464654 |
| 121 | PRKG2 | 0.41950268 |
| 122 | IGF1R | 0.41422121 |
| 123 | TIE1 | 0.41258792 |
| 124 | BRSK1 | 0.40186118 |
| 125 | MAP3K13 | 0.39774935 |
| 126 | SGK494 | 0.39269197 |
| 127 | SGK223 | 0.39269197 |
| 128 | CAMK2B | 0.38667829 |
| 129 | CDK5 | 0.38408086 |
| 130 | PRKCH | 0.38400303 |
| 131 | SRC | 0.36396031 |
| 132 | CAMK2D | 0.35661194 |
| 133 | ALK | 0.35408631 |
| 134 | PRKCQ | 0.33600249 |
| 135 | PIK3CA | 0.33434526 |
| 136 | TAOK2 | 0.33111808 |
| 137 | STK3 | 0.32465888 |
| 138 | MAP3K1 | 0.30877074 |
| 139 | PAK6 | 0.30289995 |
| 140 | CAMK2G | 0.30111822 |
| 141 | AKT2 | 0.29656132 |
| 142 | TTN | 0.28982124 |
| 143 | KSR1 | 0.27439012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nitrogen metabolism_Homo sapiens_hsa00910 | 4.34515370 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.16249631 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35594682 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31754134 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05501739 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82894083 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71351756 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66619499 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61889575 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59910715 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54052608 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51338902 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22306009 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16946758 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05587445 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.03480050 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01718329 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00797760 |
| 19 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.88789469 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86579519 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79447848 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.72572247 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67697744 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65476842 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65395690 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65150391 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64465722 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58792104 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58546310 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57069231 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56992170 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53910245 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51295208 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50383373 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40583975 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37346486 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35732700 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35484202 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28833695 |
| 40 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.28682251 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27078633 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.25464136 |
| 43 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24389038 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19551986 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18218927 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18182751 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16222621 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.08165065 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07415866 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05841897 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03183836 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00787517 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93980172 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.93526624 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92850458 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91830827 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90816966 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.88220445 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84278992 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82085672 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80918144 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77891292 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76628899 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74699464 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72556025 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70703546 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68857281 |
| 68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68140562 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68097255 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67410195 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65946341 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.64312406 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64242291 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63989941 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63888023 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62777558 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.61589301 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60740272 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58599349 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53827436 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52576174 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50721585 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50270388 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49412094 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49283664 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49170603 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47613186 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.46563052 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46236313 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45323828 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44139275 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42775116 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37868156 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36730108 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.36570304 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.36503654 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36191317 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.35883815 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35518578 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35094855 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32819060 |
| 102 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.32100780 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29695906 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27333291 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21426195 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12665389 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10735748 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10139800 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.02834860 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02510234 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00695227 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00443425 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1914162 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1859085 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | -0.1785625 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.1755242 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1736082 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1652668 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1642045 |
| 120 | Lysosome_Homo sapiens_hsa04142 | -0.1603797 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1558113 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1395468 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | -0.1261957 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1241469 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0687137 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | -0.0540903 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0532454 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0467936 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0392140 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0270240 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0185690 |

